Month: August 2017

Bruton’s Tyrosine Kinase (BTK) Inhibitors An Emerging Therapeutic Target

Articles

Bruton’s Tyrosine Kinase (BTK) is a cytoplasmic member from the Tec (tyrosine kinase expressed in hepatocellular carcinoma) group of...

Read More

The Business Cocktail

The Business Cocktail

Can-Fite Receives Milestone Payment from Korean Distribution Partner CKD Pharmaceuticals Can-Fite BioPharma Ltd., A Leading Biotechnology...

Read More

PARP Inhibitors making inroads into Ovarian Cancer

Articles

Ovarian Cancer is one of the commonly diagnosed cancer among women worldwide. It accounts for nearly 239,000 new cases and 152,000 deaths...

Read More

Friedrich’s ataxia: Rare disease

Articles

Friedreich’s ataxia is one of the rare inherited nervous system disorder which causes movement abnormalities like slowed voluntary...

Read More

Natural Killer Cell Therapies– Advancing technology increasing competition among the companies

Articles

Natural killer cells are a type of lymphocytes and are key components of the innate immune system. They are highly specific predators that...

Read More

The Business Cocktail

The Business Cocktail

Loom of Patent Expiry leads Bristol-Myers Squibb to nix 58 marketing jobs Bristol-Myers Squibb will soon bid farewell to its exclusive lock...

Read More
Close